Market Cap 233.90M
Revenue (ttm) 335.71M
Net Income (ttm) -35.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.69%
Debt to Equity Ratio 0.00
Volume 118,900
Avg Vol 230,300
Day's Range N/A - N/A
Shares Out 27.04M
Stochastic %K 83%
Beta 1.80
Analysts Sell
Price Target $11.00

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices
Sector: Healthcare
Phone: 805 562 0500
Address:
859 Ward Drive, Goleta, United States
ZacksResearch
ZacksResearch Sep. 23 at 12:51 PM
$INGN poised for growth in the POC space! 📈 🚀 Anticipating 37.5% earnings growth for 2025, driven by a strong product lineup, while strategic collaborations enhance market presence. 💰 Attractive valuation with a P/S ratio of 0.7X vs. the industry’s 2.7X. See why INGN could outperform 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-body-13632&ADID=SYND_STOCKTWITS_TWEET_2_2755480_BODY_13632
0 · Reply
ZacksResearch
ZacksResearch Sep. 23 at 11:51 AM
$INGN — time to load up? 🚀 Expanding product lineup + strong POC prospects = a bullish setup that’s hard to ignore. Discover why this stock could deserve a spot in your portfolio 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-teaser-13631&ADID=SYND_STOCKTWITS_TWEET_2_2755480_TEASER_13631
0 · Reply
macroaxis
macroaxis Sep. 21 at 7:40 AM
$INGN – Inogen Max Pain Price Drops to -1.0, Signaling Potential Bullish Momentum https://www.macroaxis.com/stock-options/INGN/Inogen-Inc?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:59 PM
IWM: Russell 2000 → $VLY Valley National $DOMO Domo $CDNA Caredx $INGN Inogen $HUMA Humacyte
0 · Reply
EquityNest
EquityNest Sep. 15 at 10:20 AM
$INGN Growth depends on demand recovery and margin discipline
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 5:33 PM
$INGN Great piece that accurately captures INGN's current position. So if you want to refresh your understanding of INGN or learn about INGN for the first time, this is essential reading. https://beyondspx.com/quote/INGN/inogen-s-resurgence-from-portable-niche-to-respiratory-powerhouse-nasdaq-ingn#analysis
1 · Reply
Rebexxinfx
Rebexxinfx Sep. 2 at 6:05 PM
$INGN woohooooo
0 · Reply
Pnmoltke
Pnmoltke Aug. 29 at 9:06 AM
$INGN I have been follwing the stock for a while and are in again at around USD 6,8. Remember this stock was almost USD 300 back in 2016 (no split😅). New management have been working on a turnaround plan that now starts to work. At the CC in august 2025 they have some comments about dobble digit revenue growth in Q4 25 and beyond. In their international business and business to business US they are growing double digit. Its their direct to consumer business that have had negative growth for 10-12 quarters. That segment now starts to stabilize according to the CC. Also recently they have introduced Voxi 5 a stationary oxygen inhalator. This segment (SOC) they have not been in before as they have focused on The POC market ( portable). The SOC market is much bigger. Their balancesheet are very healthy with a cash position of aprox. USD 124 mio. (Market cap USD 215 m). Inogen can easily run 3-5x if they start to show decent growth which I believe will start around Q4 25.
0 · Reply
FuturesFinesse
FuturesFinesse Aug. 27 at 9:49 AM
$INGN momentum slowing down, needs strength to push higher.
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 26 at 5:00 PM
$INGN why am I the only person here 🫠let’s squeeze this low floater
0 · Reply
Latest News on INGN
Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:18 PM EDT - 2 months ago

Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript


Inogen Announces Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 2 months ago

Inogen Announces Second Quarter 2025 Financial Results


Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 22, 2025, 1:38 PM EDT - 4 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough


Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 8:16 PM EDT - 5 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript


Inogen Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 5 months ago

Inogen Announces First Quarter 2025 Financial Results


A Volatile Share Price Masks Some Of The Progress At Inogen

Mar 1, 2025, 8:56 AM EST - 7 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen


What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 26, 2025, 4:21 PM EST - 7 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?


Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 8:03 PM EST - 7 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript


Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 9:55 PM EST - 11 months ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript


Inogen Announces Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 11 months ago

Inogen Announces Third Quarter 2024 Financial Results


Inogen to Present at Upcoming Investor Conferences

Nov 4, 2024, 8:30 AM EST - 11 months ago

Inogen to Present at Upcoming Investor Conferences


Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript


Inogen Announces Second Quarter 2024 Financial Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results


Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript


Inogen Announces First Quarter 2024 Financial Results

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results


Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 7:09 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript


Inogen Names Michael Bourque as New Chief Financial Officer

Jan 24, 2024, 4:00 PM EST - 1 year ago

Inogen Names Michael Bourque as New Chief Financial Officer


Inogen: Time To Be Greedy When Others Are Fearful

Jan 1, 2024, 8:47 AM EST - 1 year ago

Inogen: Time To Be Greedy When Others Are Fearful


Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 11:08 PM EST - 2 years ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript


Inogen Announces Third Quarter 2023 Financial Results

Nov 7, 2023, 4:05 PM EST - 2 years ago

Inogen Announces Third Quarter 2023 Financial Results


Inogen Completes Acquisition of Physio-Assist

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist


Inogen Announces CFO Transition Plan

Sep 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Announces CFO Transition Plan


Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 9:46 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript


Inogen Announces Second Quarter 2023 Financial Results

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Inogen Announces Second Quarter 2023 Financial Results


ZacksResearch
ZacksResearch Sep. 23 at 12:51 PM
$INGN poised for growth in the POC space! 📈 🚀 Anticipating 37.5% earnings growth for 2025, driven by a strong product lineup, while strategic collaborations enhance market presence. 💰 Attractive valuation with a P/S ratio of 0.7X vs. the industry’s 2.7X. See why INGN could outperform 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-body-13632&ADID=SYND_STOCKTWITS_TWEET_2_2755480_BODY_13632
0 · Reply
ZacksResearch
ZacksResearch Sep. 23 at 11:51 AM
$INGN — time to load up? 🚀 Expanding product lineup + strong POC prospects = a bullish setup that’s hard to ignore. Discover why this stock could deserve a spot in your portfolio 👉 https://www.zacks.com/stock/news/2755480/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2755480-teaser-13631&ADID=SYND_STOCKTWITS_TWEET_2_2755480_TEASER_13631
0 · Reply
macroaxis
macroaxis Sep. 21 at 7:40 AM
$INGN – Inogen Max Pain Price Drops to -1.0, Signaling Potential Bullish Momentum https://www.macroaxis.com/stock-options/INGN/Inogen-Inc?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
highnihilism
highnihilism Sep. 16 at 6:59 PM
IWM: Russell 2000 → $VLY Valley National $DOMO Domo $CDNA Caredx $INGN Inogen $HUMA Humacyte
0 · Reply
EquityNest
EquityNest Sep. 15 at 10:20 AM
$INGN Growth depends on demand recovery and margin discipline
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 5:33 PM
$INGN Great piece that accurately captures INGN's current position. So if you want to refresh your understanding of INGN or learn about INGN for the first time, this is essential reading. https://beyondspx.com/quote/INGN/inogen-s-resurgence-from-portable-niche-to-respiratory-powerhouse-nasdaq-ingn#analysis
1 · Reply
Rebexxinfx
Rebexxinfx Sep. 2 at 6:05 PM
$INGN woohooooo
0 · Reply
Pnmoltke
Pnmoltke Aug. 29 at 9:06 AM
$INGN I have been follwing the stock for a while and are in again at around USD 6,8. Remember this stock was almost USD 300 back in 2016 (no split😅). New management have been working on a turnaround plan that now starts to work. At the CC in august 2025 they have some comments about dobble digit revenue growth in Q4 25 and beyond. In their international business and business to business US they are growing double digit. Its their direct to consumer business that have had negative growth for 10-12 quarters. That segment now starts to stabilize according to the CC. Also recently they have introduced Voxi 5 a stationary oxygen inhalator. This segment (SOC) they have not been in before as they have focused on The POC market ( portable). The SOC market is much bigger. Their balancesheet are very healthy with a cash position of aprox. USD 124 mio. (Market cap USD 215 m). Inogen can easily run 3-5x if they start to show decent growth which I believe will start around Q4 25.
0 · Reply
FuturesFinesse
FuturesFinesse Aug. 27 at 9:49 AM
$INGN momentum slowing down, needs strength to push higher.
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 26 at 5:00 PM
$INGN why am I the only person here 🫠let’s squeeze this low floater
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 7:19 PM
$RILY just want to draw your attention to this guy that BRiley just initiated coverage on with a buy rating : $INGN. Calls are ridiculous cheap, moderately low float and she’s heating up
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 7:16 PM
$INGN $10 calls Sept19 .05 don’t mind if I dooooooooooooooooooo
0 · Reply
Rebexxinfx
Rebexxinfx Aug. 14 at 5:53 PM
$INGN golden cross incoming? 👀
0 · Reply
assisi
assisi Aug. 12 at 4:35 PM
@sogenerous thoughts on $INGN
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 5:45 PM
$INGN narrows Q2 loss, beats revenue estimates — but is the turnaround real? 📈 Inogen posted a narrower-than-expected adjusted loss per share of 2 cents, topping the Zacks Consensus Estimate of a 22-cent loss, with sales revenues increasing 4% year over year. Yet, the stock is still down 36% YTD despite a 2.7% pre-market rise today. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-body-7007&ADID=SYND_STOCKTWITS_TWEET_2_2684701_BODY_7007
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 4:39 PM
$INGN pops on Q2 beat — but is the rally just getting started? Loss narrowed and revenue climbed 4% Y/Y, powered by strong B2B demand even as DTC and rental segments slipped. Full breakdown here 👉 https://www.zacks.com/stock/news/2684701/inogen-stock-gains-following-q2-earnings-beat-revenues-up-yy?cid=sm-stocktwits-2-2684701-teaser-6960&ADID=SYND_STOCKTWITS_TWEET_2_2684701_TEASER_6960
0 · Reply
zecca1889
zecca1889 Aug. 7 at 9:24 PM
$INGN It can only get better
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 2:29 PM
$INGN poised for growth — why the POC market is a game-changer! 🚀 🩺 First-quarter revenues up 5.5% YoY, with domestic sales rising 29.9% and international sales increasing 22.9%. 📈 POCs market projected to grow from $15.05B in 2024 to $22.63B by 2029. 💡 New product launches like Voxi 5 & strategic collaborations to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-body-2050&ADID=SYND_STOCKTWITS_TWEET_2_2585365_BODY_2050
0 · Reply
ZacksResearch
ZacksResearch Jul. 16 at 12:50 PM
$INGN looks ready to breathe new life into your portfolio 👀 Expanding its product lineup and strong potential in portable oxygen concentrators (POC) are fueling bullish sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-teaser-1977&ADID=SYND_STOCKTWITS_TWEET_2_2585365_TEASER_1977
0 · Reply
MoneyTree82
MoneyTree82 Jun. 17 at 4:53 PM
$INGN low float very few shares available… would take much for this to pop hard!
0 · Reply